125 related articles for article (PubMed ID: 21087389)
1. Renal cell carcinoma: stage, grade and histology migration over the last 15 years in a large Australian surgical series.
Doeuk N; Guo DY; Haddad R; Lau H; Woo HH; Bariol S; Drummond M; Vladica P; Brooks A; Patel MI
BJU Int; 2011 May; 107(9):1381-5. PubMed ID: 21087389
[TBL] [Abstract][Full Text] [Related]
2. Trends of stage, grade, histology and tumour necrosis in renal cell carcinoma in a European centre surgical series from 1984 to 2010.
Pichler M; Hutterer GC; Chromecki TF; Jesche J; Kampel-Kettner K; Eberhard K; Hoefler G; Pummer K; Zigeuner R
J Clin Pathol; 2012 Aug; 65(8):721-4. PubMed ID: 22639409
[TBL] [Abstract][Full Text] [Related]
3. Multifocality incidence and accompanying clinicopathological factors in renal cell carcinoma.
Sargin SY; Ekmekcioglu O; Arpali E; Altinel M; Voyvoda B
Urol Int; 2009; 82(3):324-9. PubMed ID: 19440022
[TBL] [Abstract][Full Text] [Related]
4. [Transabdominal radical nephrectomy for renal cell carcinoma: an experience on 155 patients].
Chen XF; Zhou FJ; Han H; Qin ZK; Liu ZW; Yu SL; Li YH; Wang H; Hou GL
Ai Zheng; 2007 May; 26(5):528-32. PubMed ID: 17672946
[TBL] [Abstract][Full Text] [Related]
5. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
6. Local recurrence after tumour enucleation for renal cell carcinoma with no ablation of the tumour bed: results of a prospective single-centre study.
Minervini A; Serni S; Tuccio A; Raspollini MR; Di Cristofano C; Siena G; Vittori G; Saleh O; Lapini A; Carini M
BJU Int; 2011 May; 107(9):1394-9. PubMed ID: 21166766
[TBL] [Abstract][Full Text] [Related]
7. Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma.
Capitanio U; Jeldres C; Patard JJ; Perrotte P; Zini L; de La Taille A; Ficarra V; Cindolo L; Bensalah K; Artibani W; Tostain J; Valeri A; Zigeuner R; Méjean A; Descotes JL; Lechevallier E; Mulders PF; Lang H; Jacqmin D; Karakiewicz PI
BJU Int; 2009 Jan; 103(1):33-7. PubMed ID: 18990161
[TBL] [Abstract][Full Text] [Related]
8. The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy.
Haferkamp A; Pritsch M; Bedke J; Wagener N; Pfitzenmaier J; Buse S; Hohenfellner M
BJU Int; 2008 May; 101(10):1243-6. PubMed ID: 18261150
[TBL] [Abstract][Full Text] [Related]
9. Capsular involvement in patients undergoing partial nephrectomy for localized renal cell carcinoma: an adverse pathological finding?
Rouach Y; Delongchamps N; Timsit MO; Verkarre V; Fontaine E; Peyromaure M; Mejean A
BJU Int; 2010 Mar; 105(5):616-9. PubMed ID: 19681891
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of primary-tumor extension, stage and grade of nuclear differentiation in patients with renal cell carcinoma.
Fiori E; De Cesare A; Galati G; Bononi M; D'Andrea N; Barbarosos A; Izzo L; Bolognese A
J Exp Clin Cancer Res; 2002 Jun; 21(2):229-32. PubMed ID: 12148583
[TBL] [Abstract][Full Text] [Related]
11. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
[TBL] [Abstract][Full Text] [Related]
12. Correlation between size of renal cell carcinoma and its grade, stage, and histological subtype.
Tabibi A; Parvin M; Abdi H; Bashtar R; Zamani N; Abadpour B
Urol J; 2007; 4(1):10-3. PubMed ID: 17514604
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
14. Benign pathological findings in 303 Chinese patients undergoing surgery for presumed localized renal cell carcinoma.
Xiong YH; Zhang ZL; Li YH; Liu ZW; Hou GL; Liu Q; Yun JP; Zhang XQ; Zhou FJ
Int J Urol; 2010 Jun; 17(6):517-21. PubMed ID: 20370841
[TBL] [Abstract][Full Text] [Related]
15. Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
Crépel M; Jeldres C; Perrotte P; Capitanio U; Isbarn H; Shariat SF; Liberman D; Sun M; Lughezzani G; Arjane P; Widmer H; Graefen M; Montorsi F; Patard JJ; Karakiewicz PI
Urology; 2010 Feb; 75(2):271-5. PubMed ID: 19962740
[TBL] [Abstract][Full Text] [Related]
16. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
[TBL] [Abstract][Full Text] [Related]
17. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
18. Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.
Isbarn H; Patard JJ; Lughezzani G; Rioux-Leclercq N; Crépel M; Cindolo L; de la Taille A; Zini L; Villers A; Shariat SF; Bertini R; Karakiewicz PI
Urology; 2010 Jun; 75(6):1378-84. PubMed ID: 19781745
[TBL] [Abstract][Full Text] [Related]
19. Identifying the risk of disease progression after surgery for localized renal cell carcinoma.
Abel EJ; Culp SH; Meissner M; Matin SF; Tamboli P; Wood CG
BJU Int; 2010 Nov; 106(9):1277-83. PubMed ID: 20394619
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M
Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]